In silico technique was applied to screen potential of 16 compounds of 5,5-dimethylthiohydantoin derivatives as androgen antagonist. The 3D structure of the protein was obtained from PDB database. Docking analysis of the compounds was performed using hex docking. Molecular modeling analysis exhibits relatively low LUMO-HOMO energy gap of the studied molecules, indicating that it would be kinetically stable. None of the compounds violated Lipinski's parameters, making them potentially promising agents for biological activities. The title compounds exhibited the lowest docking energy of protein-ligand complex. Finally, the results indicate that these compounds are potentially as an androgen antagonist, and expected to be effective in prostate cancer treatment.
Molecular Dynamics Simulation
In the present study, Bioinformatics tools are used, biological databases like PDB (Protein Data Bank) and the software's like Hex [45] . The Protein Data Bank (PDB) is the single worldwide archive of structural data of biological macromolecules, established in Brookhaven National Laboratories [46] . It contains structural information of the macromolecules determined by X-ray crystallographic and NMR methods. The structure of the androgen receptor (Figure 1) , which is an essential target for the hydroxyflutamide drug was retrieved from PDB (2AX6). On the other hand, most favored regions of the target structure were evaluated through Ramchandran plot analysis via PROCHECK [47] from SAVES Server (http://services.mbi.ucla.edu/SAVES/) to investigate the quality of the target structure.
Activity Prediction
The activity prediction of all molecules has been achieved by PASS server and compared with hydroxyflutamide. PASS Online predicts over 3500 kinds of biological activity, including pharmacological effects, mechanisms of action, toxic and adverse effects, interaction with metabolic enzymes and transporters, influence on gene expression, etc. Prediction is based on the analysis of structure activity-relationships for more than 250,000 biologically active substances including drugs, drug-candidates, leads and toxic compounds. The structural formula only is necessary to obtain the predicted biological activity profile for any compound.
HEX Docking
Hex is an interactive molecular graphics program for calculating and displaying feasible docking modes of pairs of protein and DNA molecules. Hex can also calculate protein-ligand docking; assuming the ligand is rigid, and it can superpose pairs of molecules using only knowledge of their 3D shapes [48] . It uses spherical polar fourier (SPF) correlations to accelerate the calculations and its one of the few docking programs, which have been built in graphics to view the result [49] . The docking analysis of hydroxyflutamide with androgen receptor was carried by HEX docking software. Docking allows the scientist to virtually screen a database of compounds and predict the strongest binders based on various scoring functions. It explores ways in which two molecules, such as drugs and an enzyme; Human estrogen receptor fit together and docks to each other well, like pieces of a three-dimensional jigsaw puzzle. The molecules binding to a receptor, inhibit its function, and thus act as a drug.
The parameters used in the docking process were Figure 1 . The structure of androgen receptor (2AX6).
• Correlation type-Shape only
All water molecules and ligands were removed from the proteins for docking studies. The hydroxyflutamide and 5,5-dimethylthiohydantoin derivatives were docked with the receptor using the above parameters. Visualization of the docked pose had been done using a PyMol molecular graphics program [50] .
LigPlot+ v.1.4.5
Two-dimensional representations of the best docking pose for selected 5,5-dimethylthiohydantoin derivatives inside target enzyme were generated using LigPlot+ [51] . It is a computer program which generates the schematic 2-D image of the docked protein-ligand complexes. The 3-D structure of the docked complex is input as PDB file and the software produces their interacting residues and bonds. In the present study, LigPlot+ was used to identify interacting residues as well as the interacting bonds between 2AX6 and the docked inhibitors.
Computed Atlas of Surface Topography of Proteins (CASTp)
Binding sites and active sites of proteins and DNAs are often associated with structural pockets and cavities. CASTp server uses the weighted Delaunay triangulation and the alpha complex for shape measurements. It provides identification and measurements of surface accessible pockets as well as interior inaccessible cavities, for proteins and other molecules. It measures analytically the area and volume of each pocket and cavity, both in the solvent accessible surface (SA, Richards' surface) and molecular surface (MS, Connolly's surface). It also measures the number of the mouth openings, area of the openings, and circumference of mouth, lips, in both SA and MS surfaces for each pocket [52] .
Prediction of ADMET Properties
The ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicity) properties of the target compounds were calculated using some web-based applications. BBB (Blood-Brain Barrier) penetration, HIA (Human Intestinal Absorption), Caco-2 cell permeability and Ames test were calculated using admetSAR [53] .
Results and Discussions

Molecular Modeling
The frontier molecular orbitals for all compounds have been presented in Figures 2(a)-(d) . The molecular orbital shows that, the location of possible sites responsible for electron transfer between molecules and its biological target. Thus, we can discover that how molecules react and where is the active sites in reaction. For the molecules 1-10, the HOMO are delocalized on thiohydantoin system and part of the benzene ring, while in the LUMO, the electron density predominantly are located on the benzene ring, C≡N group, thiohydantoin system except N atom which linked to benzene ring and C=O group. On the other hand, in the case of the molecules 11 and 12, the HOMO are delocalized on thiohydantoin system and part of the benzene ring, while in the LUMO, the electron density predominantly are located on the benzene ring, C≡N group, thiohydantoin system and CH 2 -SO 2 -NH 2 system. However, in the case of the molecule 13, the HOMO are delocalized on thiohydantoin system, the benzene ring and O atom linked to phenyl ring, while in the LUMO, the electron density predominantly are located on the benzene ring, C≡N group, thiohydantoin system and CH 2 -SO 2 -NH 2 system. In the case of molecule 14, the HOMO are delocalized on thiohydantoin system, Cl atom and part of the benzene ring, while in the LUMO, the electron density predominantly are located on the benzene ring, C≡N group, thiohydantoin system, Cl atom and SO 2 system. But, the HOMO of molecule 15 are delocalized on thiohydantoin system, while in the LUMO, the electron density predominantly located are on the benzene ring, C≡N group and thiohydantoin system. However, the HOMO of molecule 16 are delocalized on thiohydantoin system, while in the LUMO, the electron density predominantly are located on the benzene ring, C≡N group and part of The energies of the frontier orbital (EHOMO and ELUMO) obtained with the AM1 semiempirical method are presented in Table 3 . From these results, we can consider the compounds with larger values of EHOMO as being more electron donor and the compounds with smaller values of ELUMO as being more electron acceptor. From Table 3 , it can be seen that, the EHOMO and ELUMO calculated values present significant differences: the values of EHOMO vary from −0.32712 au to −0.34521 au and the ELUMO values vary from −0.04819 au to −0.02938 au. HOMO-LUMO refers to the energetic difference of HOMO and LUMO. Such an energetic gap can be used as an indicator of chemical reactivity, where the low energy gap correlates to high chemical reactivity and vice versa. Considering the chemical hardness, large HOMO-LUMO gap means a hard molecule and small HOMO-LUMO gap means a soft molecule. One can also relate the stability of the molecule to hardness, which means that the molecule with least HOMO-LUMO gap means it, is more reactive. Relatively low LUMO-HOMO energy gap of the studied molecules indicates that, it would be kinetically stable. According to AM1 calculation, the heat of formation (HF) energy of the studied molecules has a negative sign ( Table 3) , and they are exothermic. However, the exothermic nature of HF makes the studied molecules thermodynamically stable [54] .
In the framework of density functional theory (DFT) global descriptors of chemical reactivity corresponds to global responses of systems to global perturbations (for instance, changes in the number of electrons N), whereas the external potential remains constant. Among such types of indexes, chemical potential (μ), chemical hardness (η) and softness (s) can be used as complementary tools in the description of thermodynamic aspects of chemical reactivity.
From equation (1), the first order partial derivatives of total energy (E) with respect to the number of electrons (N) at constant external potential, ( ) V r , define chemical potential (μ). On the other hand according to equation (2) the second partial derivatives of total energy (E) with respect to the number of electrons (N) at constant external potential, ( ) V r , define the global hardness (η) of the system [55] . Operational schemes for the calculation of chemical hardness are based on a finite difference method and thus, ( )
( )
where, I·P = Ionization Potential and E·A = Electron Affinity. Using the Koopmans' theorem in terms of the energies of highest occupied molecular orbital (EHOMO) and lowest unoccupied molecular orbital (ELUMO), according equation (5) & (6) as follow
So that, the equation 3 & 4 can be expressed as follows.
Electron affinity refers to the capability of the ligand to accept precisely one electron from a donor. However, in many kinds of bonding viz. covalent hydrogen bonding, partial charge transfer takes places. Softness (S) is a property of the compound that measures the extent of chemical reactivity. It is the reciprocal of hardness.
Recently Parr et al. [56] have defined a new descriptor quantity of the global electrophilic power as an electrophilicity index (w) of the compound, which defines a quantitative classification of the global electrophilic nature of a compound. Parr et al. have proposed electrophilicity index (w) as a measure of energy lowering due to maximal electron flow between donor and acceptor. They defined electrophilicity index (w) as follows. 
This index measures the stabilization in energy when the system acquired an additional electronic charge from the environment. Electrophilicity encompasses both the abilities of an electrophile to acquire an additional electronic charge and the resistance of the system to exchange electronic charge with the environment. It contains information about both electron transfer (chemical potential) and stability (hardness) and is a better descriptor of global chemical reactivity. On the other hand, electron affinity (EA) ionization potential (IP), molecular softness, electrophilic index and electronegativity (X) were derived from these results of HOMO and LUMO as per Table 4 . It is seen that the chemical potential of the title compound is negative, and it means that the compound is stable. They do not decompose spontaneously into the elements they are made up of. The hardness signifies the resistance towards the deformation of the electron cloud of chemical systems under small perturbation encountered during the chemical process.
Molinspiration Calculations
A computational study for prediction of ADME properties of all molecules is presented in Table 5 . The number of rotatable bonds and Lipinski's rule of five were also calculated [57] . The rule states that most molecules with good membrane permeability have logP ≤ 5, molecular weight ≤ 500, a number of hydrogen bond acceptors ≤ 10, and a number of hydrogen bond donors ≤ 5. This rule is widely used as a filter for drug-like properties. Furthermore, none of the compounds violated Lipinski's parameters, making them potentially promising agents for biological activities. On the other hand, the number of rotatable bonds is important for conformational changes of molecules under study and ultimately for the binding with receptors or channels. It is revealed that for passing oral bioavailability criteria, a number of rotatable bonds should be ≤10 [58] . The compounds in this series, in general, possess a high number of rotatable bonds (5 -7) and therefore, exhibit conformational flexibility. Topological Polar Surface Area (TPSA) is calculated based on the methodology published by Ertl et al., as a sum of fragment-based contributions [59] [60] in which O-and N-centered polar fragments are to be considered and calculated by surface areas that are occupied by oxygen and nitrogen atoms, and by hydrogen atoms attached to them. TPSA has been shown to be a very good descriptor characterizing drug absorption, including intestinal absorption, bioavailability, Caco-2 permeability and blood-brain barrier penetration. Thus, the TPSA is closely related to the hydrogen bonding potential of a compound [61] . It was found that passively absorbed molecules with a TPSA more than 140 Å are thought to have low oral availability [62] . In respect of TPSA, all the compounds were found within the limit, i.e. 140 Å, which implies that molecules are fulfilling the optimal requirement for drug absorption. TPSA was used to calculate the percentage of absorption (% ABS) following the equation: % ABS = 109 -(0.345 × TPSA) as reported [63] . From all these parameters, it can be observed that all the title compounds exhibited a moderate % ABS ranging from 67.76% to 83.69%.
Calculation of Bioactivity Scores
The activity of all test compounds and the standard drug (Flutamide) were rigorously analyzed under four criteria of known successful drug activity in areas of GPCR ligand, ion channel modulator, kinase inhibitor and nuclear receptor ligand. For average organic molecules, the probability is that, if the bioactivity score is more than 0 then it is active if −0.5 to 0 then moderately active [64] . As per Table 6 , it is readily seen that all the compounds are expected to have near similar activity to standard drugs used based upon these four rigorous criteria (GPCR ligand, ion channel modulator, kinase inhibitor, and nuclear receptor ligand).
Osiris Calculations
The toxicity risks (mutagenicity, tumorigenicity, irritation, reproduction) were calculated by the methodology developed by Osiris. The toxicity risks predictor locates fragments within a molecule, which indicates a potential toxicity risk. Toxicity risk alerts are an indication that the drawn structure may be harmful concerning the risk category specified. From the data evaluated in Table 7 , it is obvious that all molecules are supposed to be non-mutagenic, non-irritating with no-reproductive effects when run through the mutagenicity assessment system in comparison with the standard drug.
The Aqueous Solubility
The aqueous solubility (S) of a compound significantly affects its absorption and distribution characteristics. Typically, a low solubility goes along with a bad absorption, and therefore the general aim is to avoid poorly soluble compounds. Our estimated logS value is a unit stripped logarithm (base 10) of a compound's solubility measured in mol/liter. There are more than 80% of the drugs on the market have an (estimated) logS value greater than −4. In the case of title compounds, values of logS are around −4. Further, Table 8 shows the drug-likeness (DL) of title compounds which are in the comparable zone with that of standard drug used for comparison. We have calculated overall drug score (DS) for the compounds 1 -16 and compared with that of standard Hydroxyflutamide. The drug score combines drug-likeness, m i LogP, logS, molecular weight and toxicity risks in one handy value then may be used to judge the compound's overall potential to qualify for a drug. This value is calculated by multiplying contributions of the individual properties according to the following equation.
( ) (1, 5) , (0.012, −6) and (1, 0) for m i LogP, logS, molecular weight and drug-likeness, respectively. The ti is the contributions taken from the four toxicity risk types and the values are 1.0, 0.8 and 0.6 for no risk, medium risk and high risk, respectively. From this work, all compounds showed moderate to good drug score as compared with the standard drug used.
Ramachandran Plot Analysis
The Ramachandran plot analysis for androgen receptor PDB (2AX6) revealed that, the 2AX6 is an excellent choice which is in good quality to use as a target for docking studies with the title compounds. The percentage of residues in the most favored-regions was 94.1% in 2AX6 (above the cut off 75%), and the percentage of residues in additional allowed regions was 5.9% in 2AX6. This result suggests that the target enzyme's structure was of good quality.
Prediction of Activity
PASS (Prediction of Activity Spectra) [64] is an online tool which predicts almost 900 types of activities based on the structure of a compound. The activity prediction of all title compounds has been achieved by PASS server and compared with hydroxyflutamide. As it can be seen in Table 9 , the designed ligands as well hydroxyflutamide when examine in the server as a smile format shows the significant properties like "Androgen antagonist and prostate cancer treatment" which predicts that the designed ligands will probably be effective to treat prostate cancer as that of hydroxyflutamide. Based on this we decided to evaluate the in silico anti-cancer activity of the title compounds against the human androgen receptor enzyme (2AX6). 
Hex Docking
Docking results between androgen receptor 2AX6 and 5,5-dimethylthiohydantoin derivatives are reported in Table 10 . The molecular docking study of the title compounds with human androgen receptor shows that, all the title compounds are showing better docking score than that of hydroxyflutamide which predicts that the title compounds have the better binding affinity to the androgen receptor than hydroxyflutamide. Among all the designed compounds, the compound 8 shows the better docking score (Figure 3) . This prediction leads us to believe that, the title compounds will possibly be suitable for treatment of prostate cancer.
Active Sites Identification
In order to find the active sites, the Castp Server is used. The PDB file is used as an input and the results are obtained from this tool which explains the total number of active sites present in the Query PDF file along with information on their amino acid sequence. In addition to that, it also gives their area and volume of the pockets. Pockets are empty concavities on a protein surface into which solvent (probe sphere 1.4 A) can gain access, i.e., these concavities have mouth openings connecting their interior with the outside bulk solution. Currently, shallow depressions are excluded from the calculation. In 2AX6 there are 33 pockets presented in Figure 4 . On the other hand, the details of the pocket area, volume, positions and amino acids are given in Table 11 . The results obtained from the Castp server revealed that, the 32 nd pocket has a maximum area of 379.7 mm 2 and Volumes of 473.2 mm 3 . Further the amino acids like ILE, MET, PHE, LEU, ALA, PHE, LEU, ALA, PHE, LEU, MET, MET, PHE, ARG, MET, VAL, MET, MET, TRP, GLN, GLY, LEU, ASN, LEU, LEU are presented in this pocket.
Lig Plot +
The interactions of each compound with the functional residues of 2AX6 demonstrated that all the ligands interact with most of the residues in the binding pocket as shown in Figure 5(a)-(d) . Compound 1 had no hydrogen bond interaction with the protein, but got two external bonds with His789. Also, compound 1 got hydrophobic interaction with Leu790, Val785, Ile869, Arg786, Ser865, Lys861, Leu862 and Glu793. Also, compound 2 had no hydrogen bond interaction with the protein, but got the hydrophobic interaction with Val713, Leu712, Met894, Glu893, Glu897, Gln738, Met734 and Val716. Compound 3 was found to show two hydrogen bonds interaction with active site amino acid residues Gln902 and Met734 at a distance of 2.43 and 2.9 respectively, and the hydrophobic interaction with Lys720, Gln733, Val730, Lys822, Asp732, Ala735, Asp731 and Gln738. Compound 4 was found to show three hydrogen bonds interaction with Ala735, Gln902 and Lys822 a distance of 2.65, 3.02 and 2.84 respectively, and the hydrophobic interaction with Val911, Tyr739, Lys910, Pro817, Lys905, Lue821, Gly820, Asp732, Asp731 and Gln738. On the other hand, compound 5 had no hydrogen bond interaction with Figure 4 . The pockets in androgen receptor (2AX6). the protein, but got the hydrophobic interaction with Glu793, Lys861, Leu862, Arg786, Ill869, His789, Ser865 and Lue797. Also, compound 6 had no hydrogen bond interaction with the protein, but got the hydrophobic interaction with Glu793, Lys861, His789, Ile869, Ar786, Ser865, Lue862 and Leu797. However, compound 7 was found to show three hydrogen bonds interaction with Ala735, Gln902 and Lys822 a distance of 2.61, 3.19 and 2.85 respectively, and the hydrophobic interaction with Tyr739, Lys910, Pro817, Asp732, Asp731, Asp819 and Gln738. Moreover, compound 8 had no hydrogen bond interaction with the protein, but got the hydrophobic interaction with Lys717, Val713, Met734, Glu893, Glu897, Gln738, Met894, Leu712 and Val716. However, compound 9 had no hydrogen bond interaction with the protein but got two external bonds with Val 684 and Thr755. Furthermore, this compound got hydrophobic interaction with Trp751, Asn756, Arg752, Gln711, Val685, Gly683, Glu681, Pro682, Phe804 and Ala748. On the other hand, compound 10, was found to show one hydrogen bond interaction with Gln902 a distance of 2.72 and the hydrophobic interaction with Gln738, Ala735, Asp731, Asp732, Lys822, Lys905, Val911, Asp819 and Pro817. Compound 11 had no hydrogen bond interaction with the protein, but got the hydrophobic interaction with Pro817, Lys822, Asp731, Met734, Gln738 and Ala735. On the other hand, compound 12, was found to show one hydrogen bond interaction with Ser865 a distance of 2.77 and the hydrophobic interaction with Tyr915, Asp864, Pro868, Glu793, Glu793, Gln858, Lys861, Tyr857 and Leu797. Compound 13, was found to show one hydrogen bond interaction with Gln802 a distance of 2.23, but got two external bonds with Phe804 and Thr755, and the hydrophobic interaction with Asn756, Arg752, Trp751, Glu681, Leu805, Pro801 and Glu678. However, compound 14 had no hydrogen bond interaction with the protein, but got four external bonds with Ile869, Met787, Phe794 and Leu862, also this compound got hydrophobic interaction with Arg786, Ser865, Glu793, Leu797, Ser791, Phe747, Gly 750 and Val746. However, compound 15 had no hydrogen bonds interaction with the protein, but got hydrophobic interaction with Arg786, Ser865, Glu793, Leu797, His789, Ile869, Lys861, and Leu862. On the other hand, compound 16 was found to show one hydrogen bond interaction with Trp751 a distance of 3.13, but got the hydrophobic interaction with Pro682, Gly683, Val684, Glu681, Phe804, Pro801, Leu805, Gln802 and Glu678. The interactions of hydroxyflotamide with the functional residues of 2AX6 presented in figure in (Figure 5(e) ), it shows one hydrogen bond interaction With Val 685 a distance of 2.19, but got the hydrophobic interaction with Arg752, Gly683, Val684, Pro682, Val715, Ala748, Leu744 and Gln711.
ADMET
As discussed earlier, physicochemical properties such as molecular weight MiLogP and TPSA of all a title com-pounds follow Lipinski's Rule of Five. Furthermore, online software admetSAR (http://www.admetexp.org/predict/), were used to generate in silico pharmacokinetics parameters for all compounds in order to estimate their drug-likeness properties. Various ADMET parameters are characterized for compounds 4 and hydroxyflotamide using in silico module admetSAR. The results of the analysis can be seen in Table 12 . The analysis includes human intestinal absorption, blood-brain barrier penetration, Caco-2 permeability, P-glycoprotein substrate and inhibitor, CYP450 substrate and inhibitor (CYP1A2, 2C9, 2D6, 2C19, and 3A4), hERG inhibitors, AMES mutagenicity, carcinogens, fathead minnow toxicity, honey bee toxicity, aqueous solubility and Tetrahymena pyriformis toxicity. As per Table 12 , hydroxyflotamide is a carcinogen as compared to the non-carcinogenic nature of the compound 4. The major limitation of hydroxyflotamide is its CYP450 3A4 substrate nature, lead to high drug-drug interaction and interruption in the metabolism of the drug combination. The compound 4 overcomes that limitation. Furthermore, the compound 4 is AMES non-toxic and non-carcinogens with compared to standard drug hydroxyflotamide. Acute Oral Toxicity: Category III includes compounds with LD50 values greater than 500 mg/kg but less than 5000 mg/kg. Carcinogenicity (three-class): Carcinogenic compounds with TD50 (tumorigenic dose rate 50) B10 mg/kg body wt/day were assigned as "Danger," those with TD50 [10 mg/kg body wt/day were assigned as "Warning," and non-carcinogenic chemicals were assigned as "Non-required." Probability indicates scale between 0 and 1. Parameters indicating difference between the most active and the least compound have been highlighted in bold letters.
Conclusion
The in silico study of 5,5-dimethylthiohydantoin derivatives gives promise results for using these compounds as an androgen antagonist. The title compounds bind with more competence to the binding site of similar to hydroxyflutamide. Our study has chosen 16 molecules, which demonstrate the better result in silico analysis with better binding efficiency (in terms of docking score) towards androgen receptor than that of hydroxyflutamide.
Hydroxyflotamide is a carcinogen as compared to the non-carcinogenic nature of the compound 4. On the other hand, the compound 4 is AMES non-toxic and non-carcinogens with compared to standard drug hydroxyflotamide. Hence, it has been predicted that all the title compounds can possibly act as new leads for the treatment of prostate cancer as they possess androgen antagonist activity. These results may be used in future experiments to investigate the interactions of 5,5-dimethylthiohydantoin derivatives with the androgen receptor, or may be used in vivo experiments to test their effects on the abilities of treatment of prostate cancer.
